KOD - コディアック・サイエンシズ (Kodiak Sciences Inc) コディアック・サイエンシズ

 KODのチャート


 KODの企業情報

symbol KOD
会社名 Kodiak Sciences Inc (コディアック・サイエンシズ)
分野(sector)   
産業(industry)   
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 Kodiak Sciences Inc. is a clinical stage biopharmaceutical company. The Company is focused on developing therapeutics to treat ophthalmic diseases. The Company’s Antibody Biopolymer Conjugate (ABC) platform focuses on merging the fields of antibody-based and chemistry-based therapies. The Company in addition to its lead product candidate KSI-301 is a molecule for age-related macular degeneration and diabetic retinopathy. The Company has leveraged its ABC platform to build a pipeline of product candidates in various stages of development including KSI-501 a dual inhibitor ABC for the treatment of neovascular retinal diseases such as wet AMD and diabetic retinopathy.   コディアック・サイエンシズは米国のバイオ医薬品企業。羅漢率の高い眼科疾患のための新たな治療薬の開発に従事。主な製品候補には、加齢黄斑変性症および糖尿病性網膜症のための抗血管内皮増殖因子薬KSI-301があるほか、前臨床段階のプロジェクトとして糖尿病黄斑浮腫やぶどう膜炎の治療薬の臨床試験を手掛ける。本社所在地はカリフォルニア州パロアルト。   Kodiak Sciences Inc. is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases. Founded in 2009, Kodiak is focused on bringing new science to the design and manufacture of next generation retinal medicines to prevent and treat the leading causes of blindness globally. Its ABC Platform™ uses molecular engineering to merge the fields of antibody-based and chemistry-based therapies and is at the core of Kodiak's discovery engine. Kodiak's lead product candidate, KSI-301, is a novel anti-VEGF antibody biopolymer conjugate being developed for the treatment of retinal vascular diseases including age-related macular degeneration, the leading cause of blindness in elderly patients in the developed world, and diabetic eye diseases, the leading cause of blindness in working-age patients in the developed world. Kodiak has leveraged its ABC Platform to build a pipeline of product candidates in various stages of development including KSI-501, its bispecific anti-IL-6/VEGF biopolymer conjugate for the treatment of neovascular retinal diseases with an inflammatory component, and the company is expanding its early research pipeline to include ABC Platform based triplet inhibitors for multifactorial retinal diseases such as dry AMD and glaucoma. Kodiak is based in Palo Alto, CA.
本社所在地 2631 Hanover Street Palo Alto CA 94304 USA
代表者氏名
代表者役職名
電話番号 +1 650-281-0850
設立年月日 39965
市場名 NASDAQ National Market System
ipoyear 2018年
従業員数 28人
url www.kodiak.com
nasdaq_url https://www.nasdaq.com/symbol/kod
adr_tso
EBITDA EBITDA(百万ドル) -23.81400
終値(lastsale) 10.01
時価総額(marketcap) 0
時価総額 時価総額(百万ドル) 343.04880
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 419.03180
当期純利益 当期純利益(百万ドル) -32.48200
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Kodiak Sciences Inc revenues was not reported. Net loss increased 39% to $16.3M. Higher net loss reflects Interest Expense increase from $12K to $3.3M (expense) General and administrative increase of 85% to $3M (expense) Stock-based Compensation in SGA increase from $52K to $384K (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.33 to -$0.46.

 KODのテクニカル分析


 KODのニュース

   Kodiak Sciences Inc. (NASDAQ:KOD) Down -14.27% Over A Week, Now Can The Stock Hit Well Above -$1.29?  2022/07/02 14:00:00 Marketing Sentinel
In last trading session, Kodiak Sciences Inc. (NASDAQ:KOD) saw 0.39 million shares changing hands with its beta currently measuring 1.69. Company’s recent per share price level of $7.75 trading at $0.11 or 1.44% at ring of the bell on the day assigns it a market valuation of $400.44M. That closing price of KOD’s stock is … Kodiak Sciences Inc. (NASDAQ:KOD) Down -14.27% Over A Week, Now Can The Stock Hit Well Above -$1.29? Read More »
   Kodiak Sciences Inc. (NASDAQ: KOD) Has Succeeded In Attracting Investors This Year, The Stock Is Down -91.59% Year-To-Date  2022/06/16 12:00:00 Marketing Sentinel
Kodiak Sciences Inc. (NASDAQ:KOD)’s traded shares stood at 1.08 million during the last session, with the company’s beta value hitting 1.90. At the close of trading, the stock’s price was $7.13, to imply a decrease of -0.63% or -$0.05 in intraday trading. The KOD share’s 52-week high remains $131.97, putting it -1750.91% down since that … Kodiak Sciences Inc. (NASDAQ: KOD) Has Succeeded In Attracting Investors This Year, The Stock Is Down -91.59% Year-To-Date Read More »
   Analysts Predict How High Kodiak Sciences Inc. (KOD) Will Go.  2022/06/11 17:00:00 Stocks Register
Kodiak Sciences Inc. (NASDAQ:KOD) concluded the trading at $8.07 on Friday, June 10, with a fall of -5.17% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $8.51 and 5Y monthly beta was reading 1.91 with its price kept floating in the … Analysts Predict How High Kodiak Sciences Inc. (KOD) Will Go. Read More »
   Kodiak Sciences gain on report of it could be vulnerable to activist investor (NASDAQ:KOD)  2022/06/01 14:56:19 Seeking Alpha
Kodiak Sciences Inc. (KOD) rose 8.4% as traders circulated a report from Tuesday that biopharma company could become a target for an activist investor after its stock plunged…
   Kodiak Sciences Stock: Potential For Comeback After Trial Setback (NASDAQ:KOD)  2022/05/17 13:09:35 Seeking Alpha
Results from Kodiak''s BEACON study are expected by Q3 of 2022. Read more to learn why I believe Kodiak Sciences is a great speculative biotech play.
   Kodiak Sciences Inc Shares Fall 0.5% Below Previous 52-Week Low - Market Mover  2022/01/13 06:40:23 Kwhen Finance
Kodiak Sciences Inc (KOD) shares closed 0.5% lower than its previous 52 week low, giving the company a market cap of $3B. The stock is currently down 20.5% year-to-date, down 55.4% over the past 12 months, and up 563.5% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 1.6%. Trading Activity Trading volume this week was 56.0% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 2.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -3489.9% The company's stock price performance over the past 12 months lags the peer average by 93.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Kodiak Sciences Inc Shares Fall 2.3% Below Previous 52-Week Low - Market Mover  2022/01/11 08:29:58 Kwhen Finance
Kodiak Sciences Inc (KOD) shares closed 2.3% lower than its previous 52 week low, giving the company a market cap of $3B. The stock is currently down 14.8% year-to-date, down 53.0% over the past 12 months, and up 610.7% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 31.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 832.0% The company's stock price performance over the past 12 months lags the peer average by 76.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Kodiak Sciences Inc Shares Close in on 52-Week Low - Market Mover  2022/01/08 11:55:52 Kwhen Finance
Kodiak Sciences Inc (KOD) shares closed today at 1.6% above its 52 week low of $71.04, giving the company a market cap of $3B. The stock is currently down 14.8% year-to-date, down 51.0% over the past 12 months, and up 610.7% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 8.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 2.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 10.2% lower than its 5-day moving average, 16.0% lower than its 20-day moving average, and 27.6% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1669.5% The company's stock price performance over the past 12 months lags the peer average by 70.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   3 Lithium Stocks to watch in 2021 as EV Demand is Expected to Boost  2021/06/29 10:52:21 Kalkine Media
Summary The demand for Lithium is continuously increasing, with electric vehicles in demand. More than 50% of the Lithium produced is used in rechargeable batteries compared to 14% almost a decade ago. Lithium is a key component in rechargeable batteries, and with the rising demand for electric vehicles, lithium stocks are expected to gain momentum, especially when industries are moving towards green technologies, electric vehicles are in focus. Earlier this year, a Deloitte report highlighted that the lithium demand could double or triple by 2030. As the EV market is growing exponentially, the next two decades can be decisive as most countries are setting their net zero carbon goals, and car manufacturers are looking for cost effective transition. A US Geological Survey report stated that batteries account for about 70% of lithium consumption worldwide, followed by ceramics and glass. Most of the worlds lithium is produced by only select countries. More than 50% is contributed by Chile alone.
   What are the best penny stocks for July?  2021/06/24 14:23:41 Kalkine Media
Summary Penny stocks are widely believed to be highly volatile and risky. Penny stocks also offer potentially high returns to investors. Oilex LD and Kodal Minerals are two such stocks that can be kept an eye on in July. It is widely believed that penny stocks are extremely volatile and risky. True, there are many stocks that come under £1 that are prone to price volatility. However, theres little value in completely dismissing penny stocks as several offer potentially high returns to investors. Shares trading below £1 on UK stock exchanges is termed penny stocks. If the price of the share is low, it is considered to be a speculative investment. The definition has, however, been widened to include stocks priced above the guideline prices. Their high volatility gives an opportunity to tap growth potential. Copyright © 2021 Kalkine Media These stocks generally function on the success or failure of a business . As they do not belong to broader exchanges, they have limited oversight, and investors end up with limited government protection.
   Kodiak Sciences Inc Shares Close in on 52-Week Low - Market Mover  2022/01/08 11:55:52 Kwhen Finance
Kodiak Sciences Inc (KOD) shares closed today at 1.6% above its 52 week low of $71.04, giving the company a market cap of $3B. The stock is currently down 14.8% year-to-date, down 51.0% over the past 12 months, and up 610.7% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 8.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 2.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 10.2% lower than its 5-day moving average, 16.0% lower than its 20-day moving average, and 27.6% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1669.5% The company's stock price performance over the past 12 months lags the peer average by 70.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   3 Lithium Stocks to watch in 2021 as EV Demand is Expected to Boost  2021/06/29 10:52:21 Kalkine Media
Summary The demand for Lithium is continuously increasing, with electric vehicles in demand. More than 50% of the Lithium produced is used in rechargeable batteries compared to 14% almost a decade ago. Lithium is a key component in rechargeable batteries, and with the rising demand for electric vehicles, lithium stocks are expected to gain momentum, especially when industries are moving towards green technologies, electric vehicles are in focus. Earlier this year, a Deloitte report highlighted that the lithium demand could double or triple by 2030. As the EV market is growing exponentially, the next two decades can be decisive as most countries are setting their net zero carbon goals, and car manufacturers are looking for cost effective transition. A US Geological Survey report stated that batteries account for about 70% of lithium consumption worldwide, followed by ceramics and glass. Most of the worlds lithium is produced by only select countries. More than 50% is contributed by Chile alone.
   What are the best penny stocks for July?  2021/06/24 14:23:41 Kalkine Media
Summary Penny stocks are widely believed to be highly volatile and risky. Penny stocks also offer potentially high returns to investors. Oilex LD and Kodal Minerals are two such stocks that can be kept an eye on in July. It is widely believed that penny stocks are extremely volatile and risky. True, there are many stocks that come under £1 that are prone to price volatility. However, theres little value in completely dismissing penny stocks as several offer potentially high returns to investors. Shares trading below £1 on UK stock exchanges is termed penny stocks. If the price of the share is low, it is considered to be a speculative investment. The definition has, however, been widened to include stocks priced above the guideline prices. Their high volatility gives an opportunity to tap growth potential. Copyright © 2021 Kalkine Media These stocks generally function on the success or failure of a business . As they do not belong to broader exchanges, they have limited oversight, and investors end up with limited government protection.
   5 penny stocks under focus as they rally up to 76% in June 2021  2021/06/18 11:16:02 Kalkine Media
Summary Investing in stock markets has been largely driven by several guiding factors Money making by investing in penny stocks is highly dependent on entry and exit Zephyr Energy stock has a impressive return in June, while it gained 525% in 2021 Investing in stock markets has been largely driven by several guiding factors that ultimately influence the buying decision. When it comes to putting the money in highly volatile assets, such penny stocks, cryptocurrencies and other market-tradable securities that have a high risk profile, people only look at the upside of the investment following which they end up incurring heavy losses. However, many individuals have made a good amount of money by investing in penny stocks and cryptocurrencies , riding high on the massive spikes in the market prices of these instruments. The element of money making by investing in these assets is highly dependent on the time of your entry and exit. There are penny stocks that have lost a sizable amount of their respective market capitalisation, but have bounced back sharply, superseding previous highs.
   Kodal Minerals'' present Côte dIvoire and Mali update ahead of CEO''s West African trip  2021/06/17 10:55:00 Proactive Investors UK

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 コディアック・サイエンシズ KOD Kodiak Sciences Inc)

 twitter  (公式ツイッターやCEOツイッターなど)